Cargando…
HN1 as a diagnostic and prognostic biomarker for liver cancer
Background: The present study aimed to examine the diagnostic and prognostic value of HN1 in terms of overall survival (OS) and recurrence-free survival (RFS) in liver cancer and its potential regulatory signaling pathway. Methods: We obtained clinical data and HN1 RNA-seq expression data of liver c...
Autores principales: | Liu, Zhicheng, Yang, Dingquan, Li, Yanqing, Jiao, Yan, Lv, Guangchao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396428/ https://www.ncbi.nlm.nih.gov/pubmed/32700728 http://dx.doi.org/10.1042/BSR20200316 |
Ejemplares similares
-
BCL11A: a potential diagnostic biomarker and therapeutic target in human diseases
por: Yin, Jiawei, et al.
Publicado: (2019) -
Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer
por: Zheng, Qingyuan, et al.
Publicado: (2021) -
Salivary cortisol concentrations in police officers – a cross-sectional study in Beijing, China
por: Zhang, Yanxia, et al.
Publicado: (2020) -
Development and validation of nomogram combining serum biomarker for predicting survival in patients with resected rectal cancer
por: Fan, Shaonan, et al.
Publicado: (2019) -
Fibrinogen is a promising biomarker for chronic obstructive pulmonary disease: evidence from a meta-analysis
por: Zhou, Bo, et al.
Publicado: (2020)